ConcertAI, a leading oncology real-world evidence data and AI SaaS technology company, and Foundation Medicine, a global, ...

Scientists from the 4D Nucleome Consortium at UMass Chan Medical School mapped the human genome in 3D over time, uncovering ...

Preserved by dry, cool air and darkness, the cheetah mummies are offering scientists DNA insights into a lost population and ...

A groundbreaking cattle genome has given researchers their clearest look yet at what makes Wagyu beef so special. By ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

GeneDx Holdings WGS recently announced a strategic partnership with Komodo Health that is likely to combine its Infinity ...

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral ...

A research team led by Zhiping Weng, PhD, and Jill Moore, PhD'18, at UMass Chan Medical School, has nearly tripled the known number of potential ...

The study shows that personalized medicine demands new competences that extend beyond traditional medical training.

Biological heterogeneity in autism can illuminate precision psychiatry and improve insights from primate brain mapping data.